DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $272,971 | -20.0% | 21,460 | -11.4% | 0.17% | -17.8% |
Q2 2023 | $341,201 | +13.9% | 24,233 | +25.0% | 0.20% | +22.4% |
Q1 2023 | $299,622 | -4.0% | 19,393 | +1.8% | 0.16% | +1.2% |
Q4 2022 | $312,262 | -22.3% | 19,052 | -12.4% | 0.16% | +1.9% |
Q3 2022 | $402,000 | +42.6% | 21,744 | +1.5% | 0.16% | +52.4% |
Q2 2022 | $282,000 | -34.6% | 21,427 | +68.9% | 0.10% | -44.7% |
Q3 2021 | $431,000 | -15.0% | 12,686 | -8.4% | 0.19% | -8.7% |
Q2 2021 | $507,000 | +3.0% | 13,846 | +26.1% | 0.21% | 0.0% |
Q1 2021 | $492,000 | -19.3% | 10,979 | +2.8% | 0.21% | -17.8% |
Q4 2020 | $610,000 | +109.6% | 10,681 | +88.1% | 0.25% | +65.4% |
Q3 2020 | $291,000 | -24.6% | 5,678 | -12.1% | 0.15% | -16.4% |
Q2 2020 | $386,000 | +68.6% | 6,459 | +15.9% | 0.18% | +94.7% |
Q1 2020 | $229,000 | -42.3% | 5,572 | -12.5% | 0.09% | +44.6% |
Q4 2019 | $397,000 | -0.8% | 6,371 | -46.0% | 0.06% | -19.8% |
Q3 2019 | $400,000 | +42.3% | 11,793 | -5.3% | 0.08% | +37.3% |
Q2 2019 | $281,000 | +14.2% | 12,449 | +17.7% | 0.06% | -88.7% |
Q1 2019 | $246,000 | -0.4% | 10,578 | -10.2% | 0.52% | +1145.2% |
Q4 2018 | $247,000 | -44.1% | 11,773 | +3.1% | 0.04% | -8.7% |
Q3 2018 | $442,000 | -43.3% | 11,418 | -42.3% | 0.05% | -93.3% |
Q2 2018 | $779,000 | – | 19,795 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |